Matches in Nanopublications for { ?s ?p "[Competitive ELISAs for measuring total BSP, DSPP, MEPE, and OPN were applied to a test group of 102 subjects with prostate cancer and 110 normal subjects and a validation group of 90 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP561887.RASQNKs6yP8tVpFghVR9fnh-XYcZ7v1Qicz1CfmLHHgcI130_assertion description "[Competitive ELISAs for measuring total BSP, DSPP, MEPE, and OPN were applied to a test group of 102 subjects with prostate cancer and 110 normal subjects and a validation group of 90 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561887.RASQNKs6yP8tVpFghVR9fnh-XYcZ7v1Qicz1CfmLHHgcI130_provenance.
- NP564080.RAupGs8AwgmAhafovXL_gKbplAu7Fw669QNE_fh6TrJfs130_assertion description "[Competitive ELISAs for measuring total BSP, DSPP, MEPE, and OPN were applied to a test group of 102 subjects with prostate cancer and 110 normal subjects and a validation group of 90 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564080.RAupGs8AwgmAhafovXL_gKbplAu7Fw669QNE_fh6TrJfs130_provenance.
- NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_assertion description "[Competitive ELISAs for measuring total BSP, DSPP, MEPE, and OPN were applied to a test group of 102 subjects with prostate cancer and 110 normal subjects and a validation group of 90 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_provenance.
- NP716667.RAbC5tijBEZh-OWQtYGEe5CU-ks8TYjQM1rDYyBZclIIE130_assertion description "[Competitive ELISAs for measuring total BSP, DSPP, MEPE, and OPN were applied to a test group of 102 subjects with prostate cancer and 110 normal subjects and a validation group of 90 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716667.RAbC5tijBEZh-OWQtYGEe5CU-ks8TYjQM1rDYyBZclIIE130_provenance.
- NP911278.RAm0euj5nhxs9Jy6XAi6i94nINQF0zVYB5AdSL1VHV0Gg130_assertion description "[Competitive ELISAs for measuring total BSP, DSPP, MEPE, and OPN were applied to a test group of 102 subjects with prostate cancer and 110 normal subjects and a validation group of 90 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911278.RAm0euj5nhxs9Jy6XAi6i94nINQF0zVYB5AdSL1VHV0Gg130_provenance.
- NP385783.RAFJMiFw9t5pmwHhGb8EAnwHB5XAh9AUyc5oBDR6T1mmU130_assertion description "[Competitive ELISAs for measuring total BSP, DSPP, MEPE, and OPN were applied to a test group of 102 subjects with prostate cancer and 110 normal subjects and a validation group of 90 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385783.RAFJMiFw9t5pmwHhGb8EAnwHB5XAh9AUyc5oBDR6T1mmU130_provenance.